Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice

Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy

(2013) Miao Lu et al.   CELLULAR IMMUNOLOGY

Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis

(2013) Ana Paula Junqueira-Kipnis et al.   PLoS One

Evaluation of the Health-related Quality of Life of Children in Schistosoma haematobium-endemic Communities in Kenya: A Cross-sectional Study

(2013) Carolyn C. Terer et al.   PLoS Neglected Tropical Diseases

Time to set the agenda for schistosomiasis elimination

(2012) David Rollinson et al.   ACTA TROPICA

A Research Agenda for Helminth Diseases of Humans: Intervention for Control and Elimination

(2012) Roger K. Prichard et al.   PLoS Neglected Tropical Diseases

A Research Agenda for Helminth Diseases of Humans: The Problem of Helminthiases

(2012) Sara Lustigman et al.   PLoS Neglected Tropical Diseases

Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum)

(2011) Weidong Zhang et al.   ACTA TROPICA

Schistosomiasis vaccines

(2011) Afzal A. Siddiqui et al.   Human vaccines & immunotherapeutics

Preclinical Prophylactic Efficacy Testing of Sm-p80–Based Vaccine in a Nonhuman Primate Model of Schistosoma mansoni Infection and Immunoglobulin G and E Responses to Sm-p80 in Human Serum Samples From an Area Where Schistosomiasis Is Endemic

(2011) Gul Ahmad et al.   JOURNAL OF INFECTIOUS DISEASES

Sm‐p80–Based DNA Vaccine Provides Baboons with Levels of Protection againstSchistosomamansoniInfection Comparable to Those Achieved by the Irradiated Cercarial Vaccine

(2010) Weidong Zhang et al.   JOURNAL OF INFECTIOUS DISEASES

Heterologous prime–boost vaccination

(2009) Shan Lu   CURRENT OPINION IN IMMUNOLOGY

Transforming growth factor-β and Th17 responses in resistance to primary murine schistosomiasis mansoni

(2009) Hatem Tallima et al.   CYTOKINE

Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects

(2009) Katarina Radošević et al.   Expert Review of Vaccines

Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection withSchistosoma mansoniin mouse

(2009) W. ZHANG et al.   PARASITE IMMUNOLOGY

Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine

(2009) Gul Ahmad et al.   PARASITOLOGY RESEARCH

Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model

(2009) Gul Ahmad et al.   VACCINE

Current Status of Vaccines for Schistosomiasis

(2008) D. P. McManus et al.   CLINICAL MICROBIOLOGY REVIEWS

Experimental vaccines in animal models for schistosomiasis

(2008) Afzal A. Siddiqui et al.   PARASITOLOGY RESEARCH

Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control

(2008) Robert Bergquist et al.   PLoS Neglected Tropical Diseases